<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Access To Justice &#187; Uncategorized</title>
	<atom:link href="http://www.sokolovelaw.com/blog/category/uncategorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.sokolovelaw.com/blog</link>
	<description>Powered by Sokolove Law</description>
	<lastBuildDate>Wed, 16 Jun 2010 17:13:46 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Total Recall at Last for J&amp;J?</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/16/total-recall-at-last-for-jj/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/16/total-recall-at-last-for-jj/#comments</comments>
		<pubDate>Wed, 16 Jun 2010 17:13:46 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Product Liability]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Product Recall]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2239</guid>
		<description><![CDATA[
			
				
			
		
Johnson &#38; Johnson (J&#38;J) is recalling more of its over-the-counter medications. Again.
The health care company issued a press release yesterday announcing a recall of one lot of Extra Strength Tylenol Rapid Release Gels and four lots of Benadryl Allergy Ultratab Tablets. The action by J&#38;J’s McNeil Consumer Health Care unit was characterized as a follow-up [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/16/total-recall-at-last-for-jj/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lobster Meat Recalled For Possible Listeria Contamination</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/16/lobster-meat-recalled-for-possible-listeria-contamination/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/16/lobster-meat-recalled-for-possible-listeria-contamination/#comments</comments>
		<pubDate>Wed, 16 Jun 2010 13:07:05 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Product Liability]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[Recalls]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2227</guid>
		<description><![CDATA[
			
				
			
		
Lobster lovers take notice: Several brands of fresh or frozen lobster meat are under recall after tests found possible bacterial contamination, according to the Food and Drug Administration (FDA).
The Portland Shellfish Company is voluntarily recalling its Portland Shellfish Co. Inc brand, Claw Island, Craig’s All Natural, and Inland Ocean cooked, fresh or frozen lobster claw [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/16/lobster-meat-recalled-for-possible-listeria-contamination/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Risk Linked to Blood Pressure Drugs</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/15/cancer-risk-linked-to-blood-pressure-drugs/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/15/cancer-risk-linked-to-blood-pressure-drugs/#comments</comments>
		<pubDate>Tue, 15 Jun 2010 17:44:30 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[ARBs]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2220</guid>
		<description><![CDATA[
			
				
			
		
Millions of patients who take commonly prescribed blood pressure drugs could face an increased cancer risk.
Reuters reports that a study published online in The Lancet Oncology found that patients who took medications known as angiotensin-receptor blockers (ARBs) were 1.2 percent more likely to receive a new diagnosis of cancer over four years than those who [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/15/cancer-risk-linked-to-blood-pressure-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Reviewing Potential Benicar Heart Risks</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/14/fda-reviewing-potential-benicar-heart-risks/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/14/fda-reviewing-potential-benicar-heart-risks/#comments</comments>
		<pubDate>Mon, 14 Jun 2010 13:57:09 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[FDA]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2213</guid>
		<description><![CDATA[
			
				
			
		
Antihypertension drug Benicar is the focus of an investigation by the Food and Drug Administration (FDA), which will examine the possible increased risk of heart attacks, stroke, or sudden death in patients who use the drug.
The FDA&#8217;s announcement stressed that its review is ongoing and that the agency has not yet determined that the drug [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/14/fda-reviewing-potential-benicar-heart-risks/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VW Minivans Recalled Due to Fire Risk</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/14/vw-minivans-recalled-due-to-fire-risk/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/14/vw-minivans-recalled-due-to-fire-risk/#comments</comments>
		<pubDate>Mon, 14 Jun 2010 13:07:10 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Product Liability]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Car Recalls]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2203</guid>
		<description><![CDATA[
			
				
			
		
Nearly 16,000 Volkswagen Routan minivans are being recalled by the German automaker due to a potential fire hazard involving the latches on the sliding doors, according to a National Highway Traffic Safety Administration notice. The affected minivans are from the 2009 model year.  Under certain conditions, the internal wiring installation may cause a fire within [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/14/vw-minivans-recalled-due-to-fire-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Avandia Safety Assailed by FDA Official</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/11/avandia-safety-assailed-by-fda-official/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/11/avandia-safety-assailed-by-fda-official/#comments</comments>
		<pubDate>Fri, 11 Jun 2010 16:05:57 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Avandia]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2190</guid>
		<description><![CDATA[
			
				
			
		
GlaxoSmithKline’s diabetes drug Avandia  may be responsible for up to 48,000 heart attacks, strokes, and other serious health problems over the past decade, reports the Wall Street Journal (subscription required), citing an unpublished study by a Food and Drug Administration (FDA) scientist.
Medicare patients using Avandia (rosiglitazone ) faced greater risks of stroke (27 percent), heart [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/11/avandia-safety-assailed-by-fda-official/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ground Zero Workers Awarded $712 Million in New Deal</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/11/ground-zero-workers-awarded-712-million-in-new-deal/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/11/ground-zero-workers-awarded-712-million-in-new-deal/#comments</comments>
		<pubDate>Fri, 11 Jun 2010 14:34:40 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Workplace & Environmental]]></category>
		<category><![CDATA[World Trade Center]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2178</guid>
		<description><![CDATA[
			
				
			
		
Ground Zero rescue and cleanup workers will receive a $712 million payout from a new settlement negotiated with the City of New York to compensate them for health problems triggered by their work at the site of the 9/11 terrorist attacks on the World Trade Center, reports The New York Times.
The new settlement is significantly [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/11/ground-zero-workers-awarded-712-million-in-new-deal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Epilepsy Drug Depakote Linked to Major Birth Defects</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/10/epilepsy-drug-depakote-linked-to-major-birth-defects/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/10/epilepsy-drug-depakote-linked-to-major-birth-defects/#comments</comments>
		<pubDate>Fri, 11 Jun 2010 04:28:05 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Birth Injury]]></category>
		<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Birth Defects]]></category>
		<category><![CDATA[Depakote]]></category>
		<category><![CDATA[Spina Bifida]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2164</guid>
		<description><![CDATA[
			
				
			
		
Babies whose mothers took Depakote (valproate) during early pregnancy face a greater risk of severe birth defects than children born to women who did not use the anti-epilepsy drug, according to a study in the New England Journal of Medicine.
We’ve blogged here about the potential danger of using this drug during pregnancy, in particular the [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/10/epilepsy-drug-depakote-linked-to-major-birth-defects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alarm Sounded About Lax Infection Control at Outpatient Surgical Centers</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/10/alarm-sounded-about-lax-infection-control-at-outpatient-surgical-centers/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/10/alarm-sounded-about-lax-infection-control-at-outpatient-surgical-centers/#comments</comments>
		<pubDate>Fri, 11 Jun 2010 01:47:21 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Medical Malpractice]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Infection Control]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2152</guid>
		<description><![CDATA[
			
				
			
		
File this under things that make you go “eew”: Lax infection-control procedures at the nation’s outpatient surgical centers–where procedures from colonoscopy to plastic surgery take place–may be putting millions of patients at risk for illness, according to a newly released federal study.
Bloomberg Business News reports that the study found infection-control lapses such as a lack [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/10/alarm-sounded-about-lax-infection-control-at-outpatient-surgical-centers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Off-Label Marketing Draws Big Fines—But Bigger Profits—For Drugmakers</title>
		<link>http://www.sokolovelaw.com/blog/2010/06/09/off-label-marketing-draws-big-fines%e2%80%94but-bigger-profits%e2%80%94for-drugmakers/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/06/09/off-label-marketing-draws-big-fines%e2%80%94but-bigger-profits%e2%80%94for-drugmakers/#comments</comments>
		<pubDate>Wed, 09 Jun 2010 16:50:52 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Off-Label Marketing]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=2144</guid>
		<description><![CDATA[
			
				
			
		
Large fines appear have done little to deter the “off-label marketing” of prescription drugs by the pharmaceutical industry, according to an article in The Star-Ledger.
Off-label marketing is the practice of persuading a doctor to prescribe a drug for unapproved uses.  Some drugmakers have used this tactic to ring up millions of dollars in additional sales [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/06/09/off-label-marketing-draws-big-fines%e2%80%94but-bigger-profits%e2%80%94for-drugmakers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
